Your browser doesn't support javascript.
loading
Safety and efficacy of alirocumab in a real-life setting: the ODYSSEY APPRISE study.
Gaudet, Daniel; López-Sendón, José Luis; Averna, Maurizio; Bigot, Grégory; Banach, Maciej; Letierce, Alexia; Loy, Megan; Samuel, Rita; Manvelian, Garen; Batsu, Isabela; Henry, Patrick.
Afiliación
  • Gaudet D; ECOGENE-21 and Clinical Lipidology Unit, Community Gene Medicine Center, Department of Medicine, Université de Montréal, Chicoutimi, QC G7H 7K9, Canada.
  • López-Sendón JL; IdiPaz, CIBER-CV, UAM, Hospital Universitario La Paz, Madrid 20846, Spain.
  • Averna M; Department of Health Promotion Sciences, Maternal and Infantile Care, Internal Medicine and Medical Specialties-PROMISE, School of Medicine, University of Palermo, Palermo 90133, Italy.
  • Bigot G; IviData Life Sciences, Levallois-Perret 92300, France.
  • Banach M; Department of Hypertension, Medical University of Lodz, Lodz 90-419, Poland.
  • Letierce A; Sanofi, Chilly-Mazarin 91380, France.
  • Loy M; Sanofi, Bridgewater, NJ 08807, USA.
  • Samuel R; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
  • Manvelian G; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
  • Batsu I; Sanofi, Bridgewater, NJ 08807, USA.
  • Henry P; Hôpital Lariboisière, Service de Cardiologie, Paris 75010, France.
Eur J Prev Cardiol ; 28(17): 1864-1872, 2022 02 03.
Article en En | MEDLINE | ID: mdl-33624041

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados Tipo de estudio: Observational_studies / Risk_factors_studies País/Región como asunto: America do norte Idioma: En Revista: Eur J Prev Cardiol Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Anticuerpos Monoclonales Humanizados Tipo de estudio: Observational_studies / Risk_factors_studies País/Región como asunto: America do norte Idioma: En Revista: Eur J Prev Cardiol Año: 2022 Tipo del documento: Article